XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Sep. 30, 2022 $ 16,217 $ 60,414,959 $ (50,826,812) $ 9,604,364
Balance (in Shares) at Sep. 30, 2022 16,216,540      
Stock-based compensation 300,181 300,181
Issuance of common stock upon vesting of restricted stock units $ 22 (22)
Issuance of common stock upon vesting of restricted stock units (in Shares) 21,924      
Net loss (1,732,769) (1,732,769)
Balance at Dec. 31, 2022 $ 16,239 60,715,118 (52,559,581) 8,171,776
Balance (in Shares) at Dec. 31, 2022 16,238,464      
Balance at Sep. 30, 2022 $ 16,217 60,414,959 (50,826,812) 9,604,364
Balance (in Shares) at Sep. 30, 2022 16,216,540      
Net loss       (5,255,597)
Balance at Mar. 31, 2023 $ 16,888 61,598,345 (56,082,409) 5,532,824
Balance (in Shares) at Mar. 31, 2023 16,887,738      
Balance at Dec. 31, 2022 $ 16,239 60,715,118 (52,559,581) 8,171,776
Balance (in Shares) at Dec. 31, 2022 16,238,464      
Issuance of common stock in connection with at-the-market offering program $ 516 927,741 928,257
Issuance of common stock in connection with at-the-market offering program (in Shares) 516,484      
Issuance costs in connection with the at-the-market offering program (183,359) (183,359)
Stock-based compensation 237,628 237,628
Share repurchases for the payment of employee taxes $ (67) (98,583) (98,650)
Share repurchases for the payment of employee taxes (in Shares) (67,109)      
Issuance of common stock upon vesting of restricted stock units $ 200 (200)
Issuance of common stock upon vesting of restricted stock units (in Shares) 199,899      
Net loss (3,522,828) (3,522,828)
Balance at Mar. 31, 2023 $ 16,888 61,598,345 (56,082,409) 5,532,824
Balance (in Shares) at Mar. 31, 2023 16,887,738      
Balance at Sep. 30, 2023 $ 23,929 68,911,778 (62,686,303) 6,249,404
Balance (in Shares) at Sep. 30, 2023 23,928,945      
Issuance of common stock attributed to equity financings $ 868 1,255,403 1,256,271
Issuance of common stock attributed to equity financings (in Shares) 868,243      
Issuance costs related to equity financings (37,698) (37,698)
Stock-based compensation 308,638 308,638
Share repurchases for the payment of employee taxes $ (11) (13,548) (13,559)
Share repurchases for the payment of employee taxes (in Shares) (11,176)      
Issuance of common stock upon vesting of restricted stock units $ 45 (45)
Issuance of common stock upon vesting of restricted stock units (in Shares) 45,078      
Net loss (3,344,900) (3,344,900)
Balance at Dec. 31, 2023 $ 24,831 70,424,528 (66,031,203) 4,418,156
Balance (in Shares) at Dec. 31, 2023 24,831,090      
Balance at Sep. 30, 2023 $ 23,929 68,911,778 (62,686,303) $ 6,249,404
Balance (in Shares) at Sep. 30, 2023 23,928,945      
Issuance of common stock attributed to equity financings (in Shares)       1,461,353
Net loss       $ (6,199,990)
Balance at Mar. 31, 2024 $ 26,322 72,714,414 (68,886,293) 3,854,443
Balance (in Shares) at Mar. 31, 2024 26,321,750      
Balance at Dec. 31, 2023 $ 24,831 70,424,528 (66,031,203) 4,418,156
Balance (in Shares) at Dec. 31, 2023 24,831,090      
Issuance of common stock attributed to equity financings $ 1,461 2,092,735 $ 2,094,196
Issuance of common stock attributed to equity financings (in Shares) 1,461,353     2,329,596
Issuance costs related to equity financings (148,382) $ (148,382)
Stock-based compensation 356,858 356,858
Share repurchases for the payment of employee taxes $ (8) (11,287) (11,295)
Share repurchases for the payment of employee taxes (in Shares) (8,382)      
Issuance of common stock upon vesting of restricted stock units $ 38 (38)
Issuance of common stock upon vesting of restricted stock units (in Shares) 37,689      
Net loss (2,855,090) (2,855,090)
Balance at Mar. 31, 2024 $ 26,322 $ 72,714,414 $ (68,886,293) $ 3,854,443
Balance (in Shares) at Mar. 31, 2024 26,321,750